Guardant Health to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
Guardant Health, Inc. (Nasdaq: GH) will participate in the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco. The company's management will present and participate in a Q&A session on Monday, January 8, at 3:45 p.m. Pacific Time / 6:45 p.m. Eastern Time. Interested parties can access live and archived webcasts of the sessions on the 'Investors' section of the company website at www.guardanthealth.com.
12/20/2023 - 04:05 PM
PALO ALTO, Calif. --(BUSINESS WIRE)--
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will participate in the upcoming 42nd Annual J.P. Morgan Healthcare Conference in San Francisco .
Guardant Health’s management is scheduled to present and participate in a Q&A session on Monday, January 8, at 3:45 p.m. Pacific Time / 6:45 p.m. Eastern Time. Interested parties may access live and archived webcasts of the sessions on the “Investors” section of the company website at: www.guardanthealth.com .
About Guardant Health
Guardant Health is a leading precision medicine company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and helping doctors select the best treatment for patients with advanced cancer. For more information, visit guardanthealth.com and follow the company on LinkedIn , X (Twitter) and Facebook .
View source version on businesswire.com: https://www.businesswire.com/news/home/20231220877639/en/
Investor Contact:
investors@guardanthealth.com
Media Contact:
Melissa Marasco
press@guardanthealth.com
+1 650-647-3711
Source: Guardant Health, Inc.
What event will Guardant Health, Inc. participate in?
Guardant Health, Inc. will participate in the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco.
When will Guardant Health, Inc. present at the conference?
Guardant Health, Inc.'s management will present and participate in a Q&A session on Monday, January 8, at 3:45 p.m. Pacific Time / 6:45 p.m. Eastern Time.
Where can interested parties access the webcasts of the sessions?
Interested parties can access live and archived webcasts of the sessions on the 'Investors' section of the company website at www.guardanthealth.com.
Guardant Health Inc
NASDAQ:GH
GH Rankings
#4656 Ranked by Stock Gains
GH Stock Data
Industry
Dental Laboratories
Sector
Manufacturing
Tags
Health Services, Medical/Nursing Services, Manufacturing, Dental Laboratories
About GH
we believe conquering cancer is a big data problem. that’s why we built the world’s leading comprehensive liquid biopsy. this non-invasive tool for accessing and sequencing tumor dna is used by thousands of oncologists to help tens of thousands of advanced cancer patients. we believe the boom in cancer data acquisition we helped launch will drive important discoveries and new products. we’re working on some exciting ones, including in early detection, where the impact on patients can be profound. we’ve raised more than $500 million from investors including sequoia capital, khosla ventures, orbimed, and softbank.